T. Jones (Portsmouth (Hampshire), United Kingdom), A. Ten Brinke (Leeuwarden, Netherlands)
Late Breaking Abstract - Recurrent Neural Networks and environmental data for COPD exacerbation prediction
C. Esteban (Madrid, Spain), F. Moraza (Galdakao, Spain), P. García (Madrid, Spain), A. Aramburu (Galdakao, Spain), F. Sancho (Sevilla, Spain), L. Chasco (Galdakao, Spain), J. Gutiérrez (Galdakao, Spain), F. Conde (Galdakao, Spain), S. Resino (Vitoria, Spain), C. Esteban (Galdakao, Spain)
|   |
Late Breaking Abstract - Reimbursement for asthma care is a universal barrier to achieving asthma symptom control: the SABINA III study
E. Bateman (Cape Town, South Africa), D. Price (Singapore, Singapore), H. Wang (Taipei City, Taiwan), A. Khattab (Cairo, Egypt), P. Schonffeldt (Santiago, Chile), A. Catanzariti (Sydney, Australia), R. Van Der Valk (Cambridge, United Kingdom), M. Beekman (The Hague, Netherlands)
| |
Telehealth vs. standard care in COPD – a randomized controlled trial
F. Rassouli (St. Gallen, Switzerland), F. Baty (St. Gallen, Switzerland), M. Kohler (Zurich, Switzerland), D. Stolz (Basel, Switzerland), R. Thurnheer (Münsterlingen, Switzerland), T. Brack (Glarus, Switzerland), C. Kähler (Wangen, Germany), S. Widmer (St. Gallen, Switzerland), U. Tschirren (St. Gallen, Switzerland), N. Sievi (Zurich, Switzerland), M. Tamm (Basel, Switzerland), M. Brutsche (St. Gallen, Switzerland)
| |
Regulatory T cells and L-selectin in severe asthmatic patients treated with mepolizumab.
l. bergantini (siena, Italy), M. D'Alessandro (siena, Italy), P. Cameli (siena, Italy), A. Carleo (hannover , Germany), P. Sestini (siena, Italy), E. Bargagli (siena, Italy)
| |
Identifying subgroups of asthma patients for potential intervention using electronic medication monitors (EMM)
R. Gondalia (San Francisco, United States of America), L. Kaye (San Francisco, United States of America), D. Van Sickle (Madison, United States of America), D. Stempel (San Francisco, United States of America), M. Barrett (San Francisco, United States of America)
| |
Effect of increasing levels of pressure support (PS) with NIV on diaphragmatic function asessed using ultrasound and to identify indicators of NIV failure in patients of AECOPD with type 2 respiratory failure - Pilot study
M. Nawaz S (Bengaluru (Karnataka), India), P. Ramachandran (Bengaluru (Karnataka), India), U. Maheshwari (Bengaluru (Karnataka), India), U. Devaraj (Bengaluru (Karnataka), India)
| |
Characterising symptom ‘trajectotypes’ in patients with COPD
A. Halner (Oxford (Oxfordshire), United Kingdom), D. Nicolau (Brisbane (Queensland), Australia), M. Bafadhel (Oxford (Oxfordshire), United Kingdom)
| |
Effectiveness of community-based interventions following multi disciplinary team discussion in COPD patients
C. Rafique (Glasgow, United Kingdom), S. Smillie (Glasgow, United Kingdom), G. Jayasekera (Glasgow, United Kingdom), H. Bayes (Glasgow, United Kingdom), D. Anderson (Glasgow, United Kingdom)
| |
Clinical characteristics and disease control of US asthma patients treated in specialty clinics
B. Chipps (Sacramento, CA, United States of America), R. Zeiger (San Diego and Pasadena, CA, United States of America), D. Beuther (Denver, CO, United States of America), J. Reibman (New York, NY, United States of America), R. Wise (Baltimore, MD, United States of America), W. Mccann (Asheville, NC, United States of America), I. Gilbert (Wilmington, DE, United States of America), J. Eudicone (Wilmington, DE, United States of America), H. Gandhi (Wilmington, DE, United States of America), G. Harding (Bethesda, MD, United States of America), K. Cutts (Bethesda, MD, United States of America), M. George (New York, NY, United States of America), K. Murphy (Boys Town, NE, United States of America)
| |
Educational Intervention to increase adherence to inhaler therapy - INSPIRO Project
R. Ulmeanu (Bucuresti, Romania), R. Nedelcu (Bucuresti, Romania), R. Nemes (Bucuresti, Romania), F. Mihaltan (Bucuresti, Romania)
| |
Effectiveness of a panel of sputum markers in smokers with and without COPD to detect pulmonary progression towards functional impairment
G. Paone (Roma (RM), Italy), G. De Rose (Roma (RM), Italy), I. Piergentili (Roma (RM), Italy), D. Pellegrino (Roma (RM), Italy), J. Di Lorenzo (Roma (RM), Italy), I. Menichini (Roma (RM), Italy), I. Cuccaro (Roma (RM), Italy), G. Giannunzio (Roma (RM), Italy), D. Giannarelli (Roma (RM), Italy), P. Palange (Roma (RM), Italy)
| |
Opioid use, perhaps a harbinger of worsening COPD?
J. Lestari (Singapore, Singapore), H. Xu (Singapore, Singapore), H. Neo (Singapore, Singapore), S. Puah (Singapore, Singapore)
| |
Long-term omalizumab treatment – do drug concentration levels count?
J. Kroes (Leeuwarden, Netherlands), S. Zielhuis (Leeuwarden, Netherlands), A. Van Der Meer (Leeuwarden, Netherlands), K. De Jong (Leeuwarden, Netherlands), E. Van Roon (Leeuwarden, Netherlands), A. Ten Brinke (Leeuwarden, Netherlands)
| |
Proportion of complete responders after one year of treatment with biologics for severe asthma - Results from the nationwide Danish Severe Asthma Register.
S. Hansen (Frederiksberg, Denmark), O. Hilberg (Vejle, Denmark), C. Ulrik (Hvidovre, Denmark), M. Søndergaard (Copenhagen, Denmark), A. Von Bülow (Copenhagen, Denmark), A. Christiansen (Odense, Denmark), L. Rasmussen (Gentofte, Denmark), C. Johnsen (Gentofte, Denmark), J. Schmid (Aarhus, Denmark), A. Bjerrum (Aarhus, Denmark), A. Wimmer Aune (Aalborg, Denmark), K. Dahl Assing (Aalborg, Denmark), K. Rasmussen (Roskilde, Denmark), N. Krogh (Copenhagen, Denmark), C. Porsbjerg (Copenhagen, Denmark)
| |
The impact of maintenance oral corticosteroids (OCS) on disease burden and type-2 inflammatory signal in the Wessex Severe Asthma Cohort (WSAC)
L. Wiffen (Portsmouth, United Kingdom), T. Brown (Portsmouth, United Kingdom), L. Fox (Portsmouth, United Kingdom), T. Jones (Portsmouth, United Kingdom), K. Gove (Southampton, United Kingdom), C. Barber (Southampton, United Kingdom), S. Elliott (Portsmouth, United Kingdom), H. Rupani (Portsmouth, United Kingdom), P. Howarth (Southampton, United Kingdom), A. Chauhan (Portsmouth, United Kingdom)
| |
Predictive factors of mechanical ventilation need after NIV during acute exacerbations of COPD.
A. Ben Saad (Monastir, Tunisia), S. Joobeur (Monastir, Tunisia), A. Migaou (Monastir, Tunisia), N. Fahem (Monastir, Tunisia), S. Cheikh Mhamed (Monastir, Tunisia), N. Rouatbi (Monastir, Tunisia)
| |
Does the Outpatient Pulmonary Rehabilitation Program Affect Mortality in Patients with COPD?
Y. Varol (Izmir, Turkey), H. Sahin (Izmir, Turkey), G. Balci (Izmir, Turkey), F. Guldaval (Izmir, Turkey), O. Batum (Izmir, Turkey), G. Polat (Izmir, Turkey), A. Cirak (Izmir, Turkey)
| |
Gerd questionnaire as a tool for diagnosing GERD in patients with chronic obstructive pulmonary disease.
A. Balitskya (Barnaul, Russian Federation), E. Klester (Barnaul, Russian Federation), I. Weitzman (Barnaul, Russian Federation), K. Klester (Barnaul, Russian Federation)
| |